Cargando…
Myeloid Disease Mutations of Splicing Factor SRSF2 Cause G2‐M Arrest and Skewed Differentiation of Human Hematopoietic Stem and Progenitor Cells
Myeloid malignancies, including myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia, are characterized by abnormal proliferation and differentiation of hematopoietic stem and progenitor cells (HSPCs). Reports on analysis of bone marrow samples from patients have re...
Autores principales: | Bapat, Aditi, Keita, Nakia, Martelly, William, Kang, Paul, Seet, Christopher, Jacobsen, Jeffery R., Stoilov, Peter, Hu, Chengcheng, Crooks, Gay M., Sharma, Shalini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283046/ https://www.ncbi.nlm.nih.gov/pubmed/30004607 http://dx.doi.org/10.1002/stem.2885 |
Ejemplares similares
-
Splicing factor SRSF2-centric gene regulation
por: Li, Kun, et al.
Publicado: (2021) -
SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells
por: Liang, Yang, et al.
Publicado: (2018) -
SRSF2 is required for mRNA splicing during spermatogenesis
por: Lei, Wen-Long, et al.
Publicado: (2023) -
Relative strength of 5’ splice-site strength defines functions of SRSF2 and SRSF6 in alternative splicing of Bcl-x pre-mRNA
por: Choi, Namjeong, et al.
Publicado: (2021) -
Recurrent SRSF2 mutations in MDS affect both splicing and NMD
por: Rahman, Mohammad Alinoor, et al.
Publicado: (2020)